PE Week Wire - Friday 3/19
Summary
Rich McGinn, former CEO of Lucent and current general partner with RRE Ventures, has been named as a defendant in a civil lawsuit filed by Saudi Arabian telecom company National Group for Communications & Computers Ltd. The South Carolina General Assembly yesterday overrode a gubernatorial veto of an economic development package that included the creation of a $50 million VC fund aimed at local life sciences startups. www.reefedge.com Phase Forward Inc., a Waltham, Mass.-based provider of integrated data management solution for clinical trials and drug safety, has filed to raise $86.25 million via an IPO of common stock on the Nasdaq under proposed ticker symbol PFWD. He most recently served as a managing director with Capital Markets Services Inc., a subsidiary of General Electric Corp. www.mbly.com CoTherix Inc., a Belmont, Calif.-based drug development company, has filed to raise $70 million via an IPO of common stock on the Nasdaq under proposed ticker symbol CTRX. CoTherix was originally known as Exhale Therapeutics Inc. www.cotherix.com Momenta Pharmaceuticals Inc., a Cambridge, Mass.-based biotech company that utilizes glynomics (the study of sugars), has filed to raise $86.25 million via an IPO of common stock on the Nasdaq under proposed ticker symbol MNTA.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
